Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.432 USD | -0.67% |
|
-7.25% | +39.16% |
15/05 | Brookline Capital Upgrades Dare Bioscience to Buy From Hold, Price Target is $3 | MT |
14/05 | Transcript : Daré Bioscience, Inc., Q1 2024 Earnings Call, May 14, 2024 |
Evolution of the average Target Price on Daré Bioscience, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Daré Bioscience, Inc.
Brookline Capital Markets | |
HC Wainwright | |
JonesTrading Institutional Services | |
Roth Capital Partners |
EPS Revisions
- Stock Market
- Equities
- DARE Stock
- Consensus Daré Bioscience, Inc.